EXPD vs FDMT · P/E 26, rev $10.60B vs rev $37.0K
Expeditors International of Washington, Inc. (EXPD) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the EXPD and FDMT stock pages for the full models.
Not investment advice.